Short interest in Inhibikase Therapeutics Inc (NASDAQ:IKT) increased during the last reporting period, rising from 18.89M to 19.42M. This put 23.66% of the company's publicly available shares short.

Based on the recent average volume of 1.12M shares traded per day, it would take 17.38 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.